Send me a link:

*Text messaging rates may apply.

 Dow Down1.25% Nasdaq Down1.77%

Abbott Laboratories (ABT)

-NYSE
42.40 Down 0.46(1.08%) 12:47PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 5,244,000   5,654,941   5,369,139   5,445,920  
Cost of Revenue2,470,000  2,612,895  2,450,477  2,544,628  
Gross Profit 2,774,000   3,042,046   2,918,662   2,901,292  
Operating Expenses
Research Development387,000  386,243  356,877  362,880  
Selling General and Administrative1,762,000  1,701,473  1,734,693  1,713,834  
Non Recurring -   -   -   -  
Others174,000  197,933  196,753  197,314  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 451,000   756,397   630,339   627,264  
Income from Continuing Operations
Total Other Income/Expenses Net11,000  16,827  37,854  14,319  
Earnings Before Interest And Taxes462,000  773,224  668,193  641,583  
Interest Expense39,000  35,918  39,799  40,283  
Income Before Tax423,000  737,306  628,394  601,300  
Income Tax Expense84,000  147,884  (144,468)124,584  
Minority Interest -   -   -   -  
Net Income From Continuing Ops339,000  589,422  772,862  476,716  
Non-recurring Events
Discontinued Operations36,000  129  192,871   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 375,000   589,551   965,733   476,716  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 375,000   589,551   965,733   476,716  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.